GlobeNewswire Inc.··Genmab A/SOrbis Investment Management Builds 4.99% Stake in Danish Biotech Giant Genmab
Orbis Investment Management discloses 4.99% stake in Genmab A/S, holding 3.2M shares, signaling institutional confidence in the Danish biotech firm's strategy.
GMABAnnual General Meetingbiotechnology